Correlation Between Biotechnology Ultrasector and Sp Smallcap

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Sp Smallcap at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Sp Smallcap into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Sp Smallcap 600, you can compare the effects of market volatilities on Biotechnology Ultrasector and Sp Smallcap and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Sp Smallcap. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Sp Smallcap.

Diversification Opportunities for Biotechnology Ultrasector and Sp Smallcap

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Biotechnology and RYSVX is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Sp Smallcap 600 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sp Smallcap 600 and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Sp Smallcap. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sp Smallcap 600 has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Sp Smallcap go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Sp Smallcap

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to under-perform the Sp Smallcap. In addition to that, Biotechnology Ultrasector is 1.58 times more volatile than Sp Smallcap 600. It trades about -0.09 of its total potential returns per unit of risk. Sp Smallcap 600 is currently generating about 0.12 per unit of volatility. If you would invest  19,923  in Sp Smallcap 600 on September 15, 2024 and sell it today you would earn a total of  1,993  from holding Sp Smallcap 600 or generate 10.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biotechnology Ultrasector Prof  vs.  Sp Smallcap 600

 Performance 
       Timeline  
Biotechnology Ultrasector 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Sp Smallcap 600 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sp Smallcap 600 are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Sp Smallcap may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Biotechnology Ultrasector and Sp Smallcap Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Ultrasector and Sp Smallcap

The main advantage of trading using opposite Biotechnology Ultrasector and Sp Smallcap positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Sp Smallcap can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sp Smallcap will offset losses from the drop in Sp Smallcap's long position.
The idea behind Biotechnology Ultrasector Profund and Sp Smallcap 600 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bonds Directory
Find actively traded corporate debentures issued by US companies